TENX Insider Trading Activity and SEC Form 4 Filings
TENX insider trading summary
Over the past 12 months, insiders at Tenax Therapeutics, Inc. (TENX) reported 37 open-market purchases worth $12.8M by 8 insiders and no sales on SEC Form 4. Net insider buying was $12.8M.
Latest TENX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 21, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $551K (331,979 @ $1.66) |
| Oct 21, 2026 | Daniel Schneeberger | 10% Owner | Buy | $551K (331,979 @ $1.66) |
| Oct 20, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $406K (254,342 @ $1.60) |
| Oct 20, 2026 | Daniel Schneeberger | 10% Owner | Buy | $406K (254,342 @ $1.60) |
| Oct 19, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | $507K (336,528 @ $1.51) |
| Oct 19, 2026 | Daniel Schneeberger | 10% Owner | Buy | $507K (336,528 @ $1.51) |
| Sep 16, 2026 | Declan Doogan | Insider | Buy | $102K (53,000 @ $1.92) |
| Sep 15, 2026 | Christopher Thomas Giordano | CEO | Buy | $9K (4,850 @ $1.82) |
| Sep 11, 2026 | Thomas R Staab II | Chief Financial Officer | Buy | $11K (5,675 @ $1.94) |
| Sep 11, 2026 | Christopher Thomas Giordano | CEO | Buy | $11K (6,000 @ $1.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.